Detecting Nitrosamine content in Pharmaceutical Drugs

Chromatography

Detecting Nitrosamine content in Pharmaceutical Drugs

10 Mar, 2020

Published over 6 years ago. See the latest and most current information on Chromatography.

The news has recently been full of worldwide high-profile product recalls of various pharmaceutical drugs that have been found to contain nitrosamines. Nitrosamine are carcinogenic compounds so need to be monitored to ensure unsafe levels are not found in consumer products.

The Ellutia 800 Series TEA is the industry standard for nitrosamine detection thanks to is selectivity and sensitivity for Nitroso compounds. For testing of pharmaceutical drugs, The 800 Series TEA can be interfaced to a chemical stripping system that allows for rapid testing of ATNC (Apparent Total N-nitrosamine content). This quickly gives an accurate result for the total nitrosamine content of a sample showing both volatile and non-volatile components.  

Any positive sample can then be further analysed by an 800 Series TEA interfaced to a GC where volatile nitrosamines such as NDMA (N-Nitrosodimethylamine) can be separated and quantified.

For further information on how the Ellutia 800 Series TEA can help with the detection of nitrosamines in pharmaceutical drugs please visit

Latest News

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
AI to stop 165 million litres of water waste
Explore more Arrow
Pollution Solutions Online
AI-driven in-line inspection improves leak and air pocket detection in water networks
Explore more Arrow
Petro Online
ABB enables thermal mass flow measurement in safety-critical applications with SIL 2 certification
Explore more Arrow
Chromatography Today
Affordable liquid chromatography solvent delivery pump
Explore more Arrow